PMA device
Therapy Dual 8 Catheter,therapy 8MM Thermistor Ablation Catheter
Irvine Biomedical,Inc.(Ibi) · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD, Class III) · First FDA decision Nov 18, 2005, newest Apr 29, 2016Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
265
Naming "Therapy Dual 8"
MAUDE reports
0
Brand "Therapy Dual 8", since 2015
PubMed studies
0
Mentioning "Therapy Dual 8"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Therapy Dual 8 Catheter,therapy 8MM Thermistor Ablation Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 6 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Therapy Dual 8", any status and sponsor, newest update first.
Wuhan UniversityAcademic, hospital or other
NCT06971705 · 40 participants (planned) · Start Mar 20, 2025 · Primary completion Jul 30, 2027
Device: repetitive transcranial magnetic stimulation, rTMS; Sham repetitive transcranial magnetic stimulation, SrTMS · For: Chronic Ankle Instability, CAI; Functional Magnetic Resonance Imaging (fMRI)
Sites: Wuhan, China
- Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Treatment of Post-Traumatic Stress Disorder (PTSD)Pivotal-lookingNot yet recruiting
Massachusetts General HospitalAcademic, hospital or other
NCT07526285 · 100 participants (planned) · Start Jun 1, 2027 · Primary completion May 31, 2029
Device: Transcranial Magnetic Stimulation; Transcranial Magnetic Stimulation Sham · For: Posttraumatic Stress Disorder (PTSD)
Sites: Charlestown, Massachusetts
Qilu Hospital of Shandong UniversityAcademic, hospital or other
NCT07546877 · 40 participants (planned) · Start Apr 1, 2026 · Primary completion Jul 1, 2027
Device: repetitive transcranial magnetic stimulation · For: Post-Stroke Cognitive Impairment (PSCI); Repetitive Transcranial Magnetic Stimulation (rTMS); Stroke
Sites: Jinan, China
262 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Therapy Dual 8", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OAD
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Therapy Dual 8"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OAD.
- Blazer Open-Irrigated Ablation CatheterBoston Scientific Corp · PMA 2025
- Blazer II XP Cardiac Ablation Catheter and CableBoston Scientific · PMA 2025
- FlexAbility Ablation Catheter, Sensor EnabledAbbott Medical · PMA 2025
- THERMOCOOL SMARTTOUCH® SF CatheterBiosense Webster, Inc. · PMA 2026
- Therapy Cool Path DuoAbbott Medical · PMA 2020
- VISITAG SURPOINT External Processing Unit (EPU)Biosense Webster, Inc. · PMA 2026
- Safire TX Ablation CatheterIrvine Biomedical,Inc.(Ibi) · PMA 2022
- Therapy Cool PathIrvine Biomedical, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.